BridgeBio Oncology Therapeutics, Inc. (BBOT) — Net Asset Quality Index
BridgeBio Oncology Therapeutics, Inc. (BBOT) has a Net Asset Quality Index of 89.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $417.65 Million minus total liabilities of $45.37 Million yields net assets of $372.28 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read BBOT total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
BridgeBio Oncology Therapeutics, Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how BridgeBio Oncology Therapeutics, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 89.1%, representing net assets of $372.28 Million against total assets of $417.65 Million USD. For live market cap and overall valuation, see BridgeBio Oncology Therapeutics, Inc. (BBOT) total market value.
Annual Net Asset Quality Index for BridgeBio Oncology Therapeutics, Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for BridgeBio Oncology Therapeutics, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is BridgeBio Oncology Therapeutics, Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.7% | $411.10 Million | $448.38 Million | $37.28 Million | ▼ -5.4 pp |
| 2024 | 97.1% | $188.72 Million | $194.42 Million | $5.71 Million | ▲ +116.2 pp |
| 2023 | -19.1% | $-63.57K | $332.89K | $396.46K | ▼ -4.0 pp |
| 2022 | -15.1% | $-21.88K | $144.58K | $166.46K | ▼ -2.4 pp |
| 2021 | -12.7% | $-18.36K | $144.28K | $162.64K | — |